Glaxosmithkline | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
AbbVie USD 1.66B 3.15B 2025-03
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.13B 275M 2025-06
Aurora Cannabis CAD 32.07M 31.47M 2024-12
Bausch Health Companies USD -47000000 256M 2025-03
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 9.62M 151.88M 2025-03
Drreddys Laboratories 18.74B 431M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
GlaxoSmithKline GBP 1.89B 221M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
J&J USD 13.63B 8.21B 2025-03
Merck USD 6.77B 864M 2025-06
Novartis USD 4.53B 124M 2025-06
Pacira USD 8.71M 16.82M 2025-03
Perrigo USD 8.3M 143M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
Prestige Brands USD 73.96M 6.19M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
Takeda JPY 150.63B 257.93B 2025-06
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Zoetis USD 773M 144M 2024-12


Glaxosmithkline Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.